Current Opinion in Hematology

Papers
(The H4-Index of Current Opinion in Hematology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis62
Editorial: the new age of clinical research in clonal hematopoiesis and myeloid malignancies45
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis44
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies43
Hormetic endoplasmic reticulum stress in hematopoietic stem cells24
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia24
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective23
Deficits in our understanding of natural killer cell development in mouse and human23
Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy19
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function17
Developmental regulation of primitive erythropoiesis16
Regulation and importance of factor VIII levels in hemophilia A carriers16
Mechanisms of immunothrombosis in COVID-1916
Splicing regulation in hematopoiesis15
Disparities in acute myeloid leukemia treatments and outcomes15
Unraveling lipid metabolism for acute myeloid leukemia therapy15
The impact of obesity-induced inflammation on clonal hematopoiesis15
2.3242571353912